Peptide REHAB MIX (TB500+BPC157 10mg) OxyPharma

Catalogue entry: Peptide REHAB MIX (TB500+BPC157 10mg) OxyPharma. Labelled content: 10 mg. Listed pack: 1 vial. The amount identifies labelled product content, not an administration dose.

Identity and mechanism

REHAB MIX is a supplier product name rather than a single standardised molecule. The source associates the product with BPC-157 and TB-500, but a name and total quantity do not establish component ratios, sequence identity or the exact meaning of TB-500. Composition should be read from verified product documents, not reconstructed from the marketing title.

What the research measured

Lee and Padgett's 2021 retrospective knee-pain report included BPC-157 alone or with thymosin beta-4. Its design does not establish a validated combination formula, demonstrate superiority over single ingredients or authenticate this named mix. Separate animal BPC-157 research and full-length thymosin beta-4 studies answer different experimental questions.

Sporting claims and limitations

The sporting appeal is a combined recovery narrative. More ingredients do not automatically produce a better result, and evidence cannot simply be added across separate studies. Potential interactions, impurities and uncertainty about each ingredient complicate safety interpretation. A formulation combining uncertain materials cannot inherit the clinical characteristics of either research programme.

Product identity and documentation

For this item, the most useful information is a component-by-component specification tied to the actual lot. Check each substance's identity, modification, chemical form and amount, plus an analytical method capable of assessing a mixture. A total milligram label or a certificate testing only one component is insufficient. The selected option records the source quantity without assuming an unverified composition or supplying an injury-treatment protocol.